NOTCH3 and pulmonary arterial hypertension: The γ-secretase inhibitor dibenzazepine interferes with NOTCH 3 signaling, leading to the decreased migration and proliferation of pulmonary artery endothelial cells (PAECs) and the improvement of PAP in mouse PAH models [69,75].